- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Remdesivir (COVID-19) will have significant change from previous year. By the most conservative estimates of global Remdesivir (COVID-19) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Remdesivir (COVID-19) market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Remdesivir (COVID-19) market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Remdesivir (COVID-19), covering the supply chain analysis, impact assessment to the Remdesivir (COVID-19) market size growth rate in several scenarios, and the measures to be undertaken by Remdesivir (COVID-19) companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
5mg
10mg
50mg
100mg
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Clinics
Drug Store
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Gilead Sciences
Bright Gene
Kelun Pharma
Hunan Warrant Pharmaceutical
Hainan Haiyao
Inovio Pharmaceuticals
Borui Bio-Pharmaceutical
Berry Global Group
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Remdesivir (COVID-19) consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Remdesivir (COVID-19) market by identifying its various subsegments.
Focuses on the key global Remdesivir (COVID-19) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Remdesivir (COVID-19) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Remdesivir (COVID-19) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Remdesivir (COVID-19)?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Remdesivir (COVID-19) Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Remdesivir (COVID-19) Consumption 2015-2025
2.1.2 Remdesivir (COVID-19) Consumption CAGR by Region
2.2 Remdesivir (COVID-19) Segment by Type
2.2.1 5mg
2.2.2 10mg
2.2.3 50mg
2.2.4 100mg
2.3 Remdesivir (COVID-19) Consumption by Type
2.3.1 Global Remdesivir (COVID-19) Consumption Market Share by Type (2015-2020)
2.3.2 Global Remdesivir (COVID-19) Revenue and Market Share by Type (2015-2020)
2.3.3 Global Remdesivir (COVID-19) Sale Price by Type (2015-2020)
2.4 Remdesivir (COVID-19) Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Drug Store
2.4.4 Others
2.5 Remdesivir (COVID-19) Consumption by Application
2.5.1 Global Remdesivir (COVID-19) Consumption Market Share by Type (2015-2020)
2.5.2 Global Remdesivir (COVID-19) Value and Market Share by Type (2015-2020)
2.5.3 Global Remdesivir (COVID-19) Sale Price by Type (2015-2020)
3 Global Remdesivir (COVID-19) by Company
3.1 Global Remdesivir (COVID-19) Sales Market Share by Company
3.1.1 Global Remdesivir (COVID-19) Sales by Company (2018-2020)
3.1.2 Global Remdesivir (COVID-19) Sales Market Share by Company (2018-2020)
3.2 Global Remdesivir (COVID-19) Revenue Market Share by Company
3.2.1 Global Remdesivir (COVID-19) Revenue by Company (2018-2020)
3.2.2 Global Remdesivir (COVID-19) Revenue Market Share by Company (2018-2020)
3.3 Global Remdesivir (COVID-19) Sale Price by Company
3.4 Global Remdesivir (COVID-19) Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Remdesivir (COVID-19) Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Remdesivir (COVID-19) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Remdesivir (COVID-19) by Regions
4.1 Remdesivir (COVID-19) by Regions
4.2 Americas Remdesivir (COVID-19) Consumption Growth
4.3 APAC Remdesivir (COVID-19) Consumption Growth
4.4 Europe Remdesivir (COVID-19) Consumption Growth
4.5 Middle East & Africa Remdesivir (COVID-19) Consumption Growth
5 Americas
5.1 Americas Remdesivir (COVID-19) Consumption by Countries
5.1.1 Americas Remdesivir (COVID-19) Consumption by Countries (2015-2020)
5.1.2 Americas Remdesivir (COVID-19) Value by Countries (2015-2020)
5.2 Americas Remdesivir (COVID-19) Consumption by Type
5.3 Americas Remdesivir (COVID-19) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Remdesivir (COVID-19) Consumption by Regions
6.1.1 APAC Remdesivir (COVID-19) Consumption by Regions (2015-2020)
6.1.2 APAC Remdesivir (COVID-19) Value by Regions (2015-2020)
6.2 APAC Remdesivir (COVID-19) Consumption by Type
6.3 APAC Remdesivir (COVID-19) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Remdesivir (COVID-19) by Countries
7.1.1 Europe Remdesivir (COVID-19) Consumption by Countries (2015-2020)
7.1.2 Europe Remdesivir (COVID-19) Value by Countries (2015-2020)
7.2 Europe Remdesivir (COVID-19) Consumption by Type
7.3 Europe Remdesivir (COVID-19) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Remdesivir (COVID-19) by Countries
8.1.1 Middle East & Africa Remdesivir (COVID-19) Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Remdesivir (COVID-19) Value by Countries (2015-2020)
8.2 Middle East & Africa Remdesivir (COVID-19) Consumption by Type
8.3 Middle East & Africa Remdesivir (COVID-19) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Remdesivir (COVID-19) Distributors
10.3 Remdesivir (COVID-19) Customer
11 Global Remdesivir (COVID-19) Market Forecast
11.1 Global Remdesivir (COVID-19) Consumption Forecast (2021-2025)
11.2 Global Remdesivir (COVID-19) Forecast by Regions
11.2.1 Global Remdesivir (COVID-19) Forecast by Regions (2021-2025)
11.2.2 Global Remdesivir (COVID-19) Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Remdesivir (COVID-19) Forecast by Type
11.8 Global Remdesivir (COVID-19) Forecast by Application
12 Key Players Analysis
12.1 Gilead Sciences
12.1.1 Company Information
12.1.2 Remdesivir (COVID-19) Product Offered
12.1.3 Gilead Sciences Remdesivir (COVID-19) Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Gilead Sciences Latest Developments
12.2 Bright Gene
12.2.1 Company Information
12.2.2 Remdesivir (COVID-19) Product Offered
12.2.3 Bright Gene Remdesivir (COVID-19) Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Bright Gene Latest Developments
12.3 Kelun Pharma
12.3.1 Company Information
12.3.2 Remdesivir (COVID-19) Product Offered
12.3.3 Kelun Pharma Remdesivir (COVID-19) Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Kelun Pharma Latest Developments
12.4 Hunan Warrant Pharmaceutical
12.4.1 Company Information
12.4.2 Remdesivir (COVID-19) Product Offered
12.4.3 Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Hunan Warrant Pharmaceutical Latest Developments
12.5 Hainan Haiyao
12.5.1 Company Information
12.5.2 Remdesivir (COVID-19) Product Offered
12.5.3 Hainan Haiyao Remdesivir (COVID-19) Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Hainan Haiyao Latest Developments
12.6 Inovio Pharmaceuticals
12.6.1 Company Information
12.6.2 Remdesivir (COVID-19) Product Offered
12.6.3 Inovio Pharmaceuticals Remdesivir (COVID-19) Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Inovio Pharmaceuticals Latest Developments
12.7 Borui Bio-Pharmaceutical
12.7.1 Company Information
12.7.2 Remdesivir (COVID-19) Product Offered
12.7.3 Borui Bio-Pharmaceutical Remdesivir (COVID-19) Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Borui Bio-Pharmaceutical Latest Developments
12.8 Berry Global Group
12.8.1 Company Information
12.8.2 Remdesivir (COVID-19) Product Offered
12.8.3 Berry Global Group Remdesivir (COVID-19) Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Berry Global Group Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Remdesivir (COVID-19) Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Remdesivir (COVID-19) Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Remdesivir (COVID-19) Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of 5mg
Table 7. Major Players of 10mg
Table 8. Major Players of 50mg
Table 9. Major Players of 100mg
Table 10. Global Consumption Sales by Type (2015-2020)
Table 11. Global Remdesivir (COVID-19) Consumption Market Share by Type (2015-2020)
Table 12. Global Remdesivir (COVID-19) Revenue by Type (2015-2020) ($ million)
Table 13. Global Remdesivir (COVID-19) Value Market Share by Type (2015-2020) ($ Millions)
Table 14. Global Remdesivir (COVID-19) Sale Price by Type (2015-2020)
Table 15. Global Consumption Sales by Application (2015-2020)
Table 16. Global Remdesivir (COVID-19) Consumption Market Share by Application (2015-2020)
Table 17. Global Remdesivir (COVID-19) Value by Application (2015-2020)
Table 18. Global Remdesivir (COVID-19) Value Market Share by Application (2015-2020)
Table 19. Global Remdesivir (COVID-19) Sale Price by Application (2015-2020)
Table 20. Global Remdesivir (COVID-19) Sales by Company (2017-2019) (K Units)
Table 21. Global Remdesivir (COVID-19) Sales Market Share by Company (2017-2019)
Table 22. Global Remdesivir (COVID-19) Revenue by Company (2017-2019) ($ Millions)
Table 23. Global Remdesivir (COVID-19) Revenue Market Share by Company (2017-2019)
Table 24. Global Remdesivir (COVID-19) Sale Price by Company (2017-2019)
Table 25. Global Remdesivir (COVID-19) Manufacturing Base Distribution and Sales Area by Manufacturers
Table 26. Players Remdesivir (COVID-19) Products Offered
Table 27. Remdesivir (COVID-19) Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 28. Global Remdesivir (COVID-19) Consumption by Regions 2015-2020 (K Units)
Table 29. Global Remdesivir (COVID-19) Consumption Market Share by Regions 2015-2020
Table 30. Global Remdesivir (COVID-19) Value by Regions 2015-2020 ($ Millions)
Table 31. Global Remdesivir (COVID-19) Value Market Share by Regions 2015-2020
Table 32. Americas Remdesivir (COVID-19) Consumption by Countries (2015-2020) (K Units)
Table 33. Americas Remdesivir (COVID-19) Consumption Market Share by Countries (2015-2020)
Table 34. Americas Remdesivir (COVID-19) Value by Countries (2015-2020) ($ Millions)
Table 35. Americas Remdesivir (COVID-19) Value Market Share by Countries (2015-2020)
Table 36. Americas Remdesivir (COVID-19) Consumption by Type (2015-2020) (K Units)
Table 37. Americas Remdesivir (COVID-19) Consumption Market Share by Type (2015-2020)
Table 38. Americas Remdesivir (COVID-19) Consumption by Application (2015-2020) (K Units)
Table 39. Americas Remdesivir (COVID-19) Consumption Market Share by Application (2015-2020)
Table 40. APAC Remdesivir (COVID-19) Consumption by Countries (2015-2020) (K Units)
Table 41. APAC Remdesivir (COVID-19) Consumption Market Share by Countries (2015-2020)
Table 42. APAC Remdesivir (COVID-19) Value by Regions (2015-2020) ($ Millions)
Table 43. APAC Remdesivir (COVID-19) Value Market Share by Regions (2015-2020)
Table 44. APAC Remdesivir (COVID-19) Consumption by Type (2015-2020) (K Units)
Table 45. APAC Remdesivir (COVID-19) Consumption Market Share by Type (2015-2020)
Table 46. APAC Remdesivir (COVID-19) Consumption by Application (2015-2020) (K Units)
Table 47. APAC Remdesivir (COVID-19) Consumption Market Share by Application (2015-2020)
Table 48. Europe Remdesivir (COVID-19) Consumption by Countries (2015-2020) (K Units)
Table 49. Europe Remdesivir (COVID-19) Consumption Market Share by Countries (2015-2020)
Table 50. Europe Remdesivir (COVID-19) Value by Countries (2015-2020) ($ Millions)
Table 51. Europe Remdesivir (COVID-19) Value Market Share by Countries (2015-2020)
Table 52. Europe Remdesivir (COVID-19) Consumption by Type (2015-2020) (K Units)
Table 53. Europe Remdesivir (COVID-19) Consumption Market Share by Type (2015-2020)
Table 54. Europe Remdesivir (COVID-19) Consumption by Application (2015-2020) (K Units)
Table 55. Europe Remdesivir (COVID-19) Consumption Market Share by Application (2015-2020)
Table 56. Middle East & Africa Remdesivir (COVID-19) Consumption by Countries (2015-2020) (K Units)
Table 57. Middle East & Africa Remdesivir (COVID-19) Consumption Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Remdesivir (COVID-19) Value by Countries (2015-2020) ($ Millions)
Table 59. Middle East & Africa Remdesivir (COVID-19) Value Market Share by Countries (2015-2020)
Table 60. Middle East & Africa Remdesivir (COVID-19) Consumption by Type (2015-2020) (K Units)
Table 61. Middle East & Africa Remdesivir (COVID-19) Consumption Market Share by Type (2015-2020)
Table 62. Middle East & Africa Remdesivir (COVID-19) Consumption by Application (2015-2020) (K Units)
Table 63. Middle East & Africa Remdesivir (COVID-19) Consumption Market Share by Application (2015-2020)
Table 64. Remdesivir (COVID-19) Distributors List
Table 65. Remdesivir (COVID-19) Customer List
Table 66. Global Remdesivir (COVID-19) Consumption Forecast by Countries (2021-2025) (K Units)
Table 67. Global Remdesivir (COVID-19) Consumption Market Forecast by Regions
Table 68. Global Remdesivir (COVID-19) Value Forecast by Countries (2021-2025) ($ Millions)
Table 69. Global Remdesivir (COVID-19) Value Market Share Forecast by Regions
Table 70. Global Remdesivir (COVID-19) Consumption Forecast by Type (2021-2025) (K Units)
Table 71. Global Remdesivir (COVID-19) Consumption Market Share Forecast by Type (2021-2025)
Table 72. Global Remdesivir (COVID-19) Value Forecast by Type (2021-2025) ($ Millions)
Table 73. Global Remdesivir (COVID-19) Value Market Share Forecast by Type (2021-2025)
Table 74. Global Remdesivir (COVID-19) Consumption Forecast by Application (2021-2025) (K Units)
Table 75. Global Remdesivir (COVID-19) Consumption Market Share Forecast by Application (2021-2025)
Table 76. Global Remdesivir (COVID-19) Value Forecast by Application (2021-2025) ($ Millions)
Table 77. Global Remdesivir (COVID-19) Value Market Share Forecast by Application (2021-2025)
Table 78. Gilead Sciences Product Offered
Table 79. Gilead Sciences Remdesivir (COVID-19) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 80. Gilead Sciences Main Business
Table 81. Gilead Sciences Latest Developments
Table 82. Gilead Sciences Basic Information, Company Total Revenue (in $ million), Remdesivir (COVID-19) Manufacturing Base, Sales Area and Its Competitors
Table 83. Bright Gene Product Offered
Table 84. Bright Gene Remdesivir (COVID-19) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 85. Bright Gene Main Business
Table 86. Bright Gene Latest Developments
Table 87. Bright Gene Basic Information, Company Total Revenue (in $ million), Remdesivir (COVID-19) Manufacturing Base, Sales Area and Its Competitors
Table 88. Kelun Pharma Product Offered
Table 89. Kelun Pharma Remdesivir (COVID-19) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 90. Kelun Pharma Main Business
Table 91. Kelun Pharma Latest Developments
Table 92. Kelun Pharma Basic Information, Company Total Revenue (in $ million), Remdesivir (COVID-19) Manufacturing Base, Sales Area and Its Competitors
Table 93. Hunan Warrant Pharmaceutical Product Offered
Table 94. Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 95. Hunan Warrant Pharmaceutical Main Business
Table 96. Hunan Warrant Pharmaceutical Latest Developments
Table 97. Hunan Warrant Pharmaceutical Basic Information, Company Total Revenue (in $ million), Remdesivir (COVID-19) Manufacturing Base, Sales Area and Its Competitors
Table 98. Hainan Haiyao Product Offered
Table 99. Hainan Haiyao Remdesivir (COVID-19) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 100. Hainan Haiyao Main Business
Table 101. Hainan Haiyao Latest Developments
Table 102. Hainan Haiyao Basic Information, Company Total Revenue (in $ million), Remdesivir (COVID-19) Manufacturing Base, Sales Area and Its Competitors
Table 103. Inovio Pharmaceuticals Product Offered
Table 104. Inovio Pharmaceuticals Remdesivir (COVID-19) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 105. Inovio Pharmaceuticals Main Business
Table 106. Inovio Pharmaceuticals Latest Developments
Table 107. Inovio Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Remdesivir (COVID-19) Manufacturing Base, Sales Area and Its Competitors
Table 108. Borui Bio-Pharmaceutical Product Offered
Table 109. Borui Bio-Pharmaceutical Basic Information, Company Total Revenue (in $ million), Remdesivir (COVID-19) Manufacturing Base, Sales Area and Its Competitors
Table 110. Borui Bio-Pharmaceutical Main Business
Table 111. Borui Bio-Pharmaceutical Latest Developments
Table 112. Borui Bio-Pharmaceutical Remdesivir (COVID-19) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 113. Berry Global Group Product Offered
Table 114. Berry Global Group Remdesivir (COVID-19) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 115. Berry Global Group Main Business
Table 116. Berry Global Group Latest Developments
Table 117. Berry Global Group Basic Information, Company Total Revenue (in $ million), Remdesivir (COVID-19) Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Remdesivir (COVID-19)
Figure 2. Remdesivir (COVID-19) Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Remdesivir (COVID-19) Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Remdesivir (COVID-19) Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of 5mg
Figure 7. Product Picture of 10mg
Figure 8. Product Picture of 50mg
Figure 9. Product Picture of 100mg
Figure 10. Global Remdesivir (COVID-19) Consumption Market Share by Type (2015-2020)
Figure 11. Global Remdesivir (COVID-19) Value Market Share by Type (2015-2020)
Figure 12. Remdesivir (COVID-19) Consumed in Hospital
Figure 13. Global Remdesivir (COVID-19) Market: Hospital (2015-2020) (K Units)
Figure 14. Global Remdesivir (COVID-19) Market: Hospital (2015-2020) ($ Millions)
Figure 15. Remdesivir (COVID-19) Consumed in Clinics
Figure 16. Global Remdesivir (COVID-19) Market: Clinics (2015-2020) (K Units)
Figure 17. Global Remdesivir (COVID-19) Market: Clinics (2015-2020) ($ Millions)
Figure 18. Remdesivir (COVID-19) Consumed in Drug Store
Figure 19. Global Remdesivir (COVID-19) Market: Drug Store (2015-2020) (K Units)
Figure 20. Global Remdesivir (COVID-19) Market: Drug Store (2015-2020) ($ Millions)
Figure 21. Remdesivir (COVID-19) Consumed in Others
Figure 22. Global Remdesivir (COVID-19) Market: Others (2015-2020) (K Units)
Figure 23. Global Remdesivir (COVID-19) Market: Others (2015-2020) ($ Millions)
Figure 24. Global Remdesivir (COVID-19) Consumption Market Share by Application (2015-2020)
Figure 25. Global Remdesivir (COVID-19) Value Market Share by Application (2015-2020)
Figure 26. Global Remdesivir (COVID-19) Sales Market Share by Company in 2017
Figure 27. Global Remdesivir (COVID-19) Sales Market Share by Company in 2019
Figure 28. Global Remdesivir (COVID-19) Revenue Market Share by Company in 2017
Figure 29. Global Remdesivir (COVID-19) Revenue Market Share by Company in 2019
Figure 30. Global Remdesivir (COVID-19) Sale Price by Company in 2019
Figure 31. Global Remdesivir (COVID-19) Consumption Market Share by Regions 2015-2020
Figure 32. Global Remdesivir (COVID-19) Value Market Share by Regions 2015-2020
Figure 33. Americas Remdesivir (COVID-19) Consumption 2015-2020 (K Units)
Figure 34. Americas Remdesivir (COVID-19) Value 2015-2020 ($ Millions)
Figure 35. APAC Remdesivir (COVID-19) Consumption 2015-2020 (K Units)
Figure 36. APAC Remdesivir (COVID-19) Value 2015-2020 ($ Millions)
Figure 37. Europe Remdesivir (COVID-19) Consumption 2015-2020 (K Units)
Figure 38. Europe Remdesivir (COVID-19) Value 2015-2020 ($ Millions)
Figure 39. Middle East & Africa Remdesivir (COVID-19) Consumption 2015-2020 (K Units)
Figure 40. Middle East & Africa Remdesivir (COVID-19) Value 2015-2020 ($ Millions)
Figure 41. Americas Remdesivir (COVID-19) Consumption Market Share by Countries in 2019
Figure 42. Americas Remdesivir (COVID-19) Value Market Share by Countries in 2019
Figure 43. Americas Remdesivir (COVID-19) Consumption Market Share by Type in 2019
Figure 44. Americas Remdesivir (COVID-19) Consumption Market Share by Application in 2019
Figure 45. United States Remdesivir (COVID-19) Consumption Growth 2015-2020 (K Units)
Figure 46. United States Remdesivir (COVID-19) Value Growth 2015-2020 ($ Millions)
Figure 47. Canada Remdesivir (COVID-19) Consumption Growth 2015-2020 (K Units)
Figure 48. Canada Remdesivir (COVID-19) Value Growth 2015-2020 ($ Millions)
Figure 49. Mexico Remdesivir (COVID-19) Consumption Growth 2015-2020 (K Units)
Figure 50. Mexico Remdesivir (COVID-19) Value Growth 2015-2020 ($ Millions)
Figure 51. APAC Remdesivir (COVID-19) Consumption Market Share by Countries in 2019
Figure 52. APAC Remdesivir (COVID-19) Value Market Share by Regions in 2019
Figure 53. APAC Remdesivir (COVID-19) Consumption Market Share by Type in 2019
Figure 54. APAC Remdesivir (COVID-19) Consumption Market Share by Application in 2019
Figure 55. China Remdesivir (COVID-19) Consumption Growth 2015-2020 (K Units)
Figure 56. China Remdesivir (COVID-19) Value Growth 2015-2020 ($ Millions)
Figure 57. Japan Remdesivir (COVID-19) Consumption Growth 2015-2020 (K Units)
Figure 58. Japan Remdesivir (COVID-19) Value Growth 2015-2020 ($ Millions)
Figure 59. Korea Remdesivir (COVID-19) Consumption Growth 2015-2020 (K Units)
Figure 60. Korea Remdesivir (COVID-19) Value Growth 2015-2020 ($ Millions)
Figure 61. Southeast Asia Remdesivir (COVID-19) Consumption Growth 2015-2020 (K Units)
Figure 62. Southeast Asia Remdesivir (COVID-19) Value Growth 2015-2020 ($ Millions)
Figure 63. India Remdesivir (COVID-19) Consumption Growth 2015-2020 (K Units)
Figure 64. India Remdesivir (COVID-19) Value Growth 2015-2020 ($ Millions)
Figure 65. Australia Remdesivir (COVID-19) Consumption Growth 2015-2020 (K Units)
Figure 66. Australia Remdesivir (COVID-19) Value Growth 2015-2020 ($ Millions)
Figure 67. Europe Remdesivir (COVID-19) Consumption Market Share by Countries in 2019
Figure 68. Europe Remdesivir (COVID-19) Value Market Share by Countries in 2019
Figure 69. Europe Remdesivir (COVID-19) Consumption Market Share by Type in 2019
Figure 70. Europe Remdesivir (COVID-19) Consumption Market Share by Application in 2019
Figure 71. Germany Remdesivir (COVID-19) Consumption Growth 2015-2020 (K Units)
Figure 72. Germany Remdesivir (COVID-19) Value Growth 2015-2020 ($ Millions)
Figure 73. France Remdesivir (COVID-19) Consumption Growth 2015-2020 (K Units)
Figure 74. France Remdesivir (COVID-19) Value Growth 2015-2020 ($ Millions)
Figure 75. UK Remdesivir (COVID-19) Consumption Growth 2015-2020 (K Units)
Figure 76. UK Remdesivir (COVID-19) Value Growth 2015-2020 ($ Millions)
Figure 77. Italy Remdesivir (COVID-19) Consumption Growth 2015-2020 (K Units)
Figure 78. Italy Remdesivir (COVID-19) Value Growth 2015-2020 ($ Millions)
Figure 79. Russia Remdesivir (COVID-19) Consumption Growth 2015-2020 (K Units)
Figure 80. Russia Remdesivir (COVID-19) Value Growth 2015-2020 ($ Millions)
Figure 81. Middle East & Africa Remdesivir (COVID-19) Consumption Market Share by Countries in 2019
Figure 82. Middle East & Africa Remdesivir (COVID-19) Value Market Share by Countries in 2019
Figure 83. Middle East & Africa Remdesivir (COVID-19) Consumption Market Share by Type in 2019
Figure 84. Middle East & Africa Remdesivir (COVID-19) Consumption Market Share by Application in 2019
Figure 85. Egypt Remdesivir (COVID-19) Consumption Growth 2015-2020 (K Units)
Figure 86. Egypt Remdesivir (COVID-19) Value Growth 2015-2020 ($ Millions)
Figure 87. South Africa Remdesivir (COVID-19) Consumption Growth 2015-2020 (K Units)
Figure 88. South Africa Remdesivir (COVID-19) Value Growth 2015-2020 ($ Millions)
Figure 89. Israel Remdesivir (COVID-19) Consumption Growth 2015-2020 (K Units)
Figure 90. Israel Remdesivir (COVID-19) Value Growth 2015-2020 ($ Millions)
Figure 91. Turkey Remdesivir (COVID-19) Consumption Growth 2015-2020 (K Units)
Figure 92. Turkey Remdesivir (COVID-19) Value Growth 2015-2020 ($ Millions)
Figure 93. GCC Countries Remdesivir (COVID-19) Consumption Growth 2015-2020 (K Units)
Figure 94. GCC Countries Remdesivir (COVID-19) Value Growth 2015-2020 ($ Millions)
Figure 95. Global Remdesivir (COVID-19) Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 96. Global Remdesivir (COVID-19) Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 97. Americas Remdesivir (COVID-19) Consumption 2021-2025 (K Units)
Figure 98. Americas Remdesivir (COVID-19) Value 2021-2025 ($ Millions)
Figure 99. APAC Remdesivir (COVID-19) Consumption 2021-2025 (K Units)
Figure 100. APAC Remdesivir (COVID-19) Value 2021-2025 ($ Millions)
Figure 101. Europe Remdesivir (COVID-19) Consumption 2021-2025 (K Units)
Figure 102. Europe Remdesivir (COVID-19) Value 2021-2025 ($ Millions)
Figure 103. Middle East & Africa Remdesivir (COVID-19) Consumption 2021-2025 (K Units)
Figure 104. Middle East & Africa Remdesivir (COVID-19) Value 2021-2025 ($ Millions)
Figure 105. United States Remdesivir (COVID-19) Consumption 2021-2025 (K Units)
Figure 106. United States Remdesivir (COVID-19) Value 2021-2025 ($ Millions)
Figure 107. Canada Remdesivir (COVID-19) Consumption 2021-2025 (K Units)
Figure 108. Canada Remdesivir (COVID-19) Value 2021-2025 ($ Millions)
Figure 109. Mexico Remdesivir (COVID-19) Consumption 2021-2025 (K Units)
Figure 110. Mexico Remdesivir (COVID-19) Value 2021-2025 ($ Millions)
Figure 111. Brazil Remdesivir (COVID-19) Consumption 2021-2025 (K Units)
Figure 112. Brazil Remdesivir (COVID-19) Value 2021-2025 ($ Millions)
Figure 113. China Remdesivir (COVID-19) Consumption 2021-2025 (K Units)
Figure 114. China Remdesivir (COVID-19) Value 2021-2025 ($ Millions)
Figure 115. Japan Remdesivir (COVID-19) Consumption 2021-2025 (K Units)
Figure 116. Japan Remdesivir (COVID-19) Value 2021-2025 ($ Millions)
Figure 117. Korea Remdesivir (COVID-19) Consumption 2021-2025 (K Units)
Figure 118. Korea Remdesivir (COVID-19) Value 2021-2025 ($ Millions)
Figure 119. Southeast Asia Remdesivir (COVID-19) Consumption 2021-2025 (K Units)
Figure 120. Southeast Asia Remdesivir (COVID-19) Value 2021-2025 ($ Millions)
Figure 121. India Remdesivir (COVID-19) Consumption 2021-2025 (K Units)
Figure 122. India Remdesivir (COVID-19) Value 2021-2025 ($ Millions)
Figure 123. Australia Remdesivir (COVID-19) Consumption 2021-2025 (K Units)
Figure 124. Australia Remdesivir (COVID-19) Value 2021-2025 ($ Millions)
Figure 125. Germany Remdesivir (COVID-19) Consumption 2021-2025 (K Units)
Figure 126. Germany Remdesivir (COVID-19) Value 2021-2025 ($ Millions)
Figure 127. France Remdesivir (COVID-19) Consumption 2021-2025 (K Units)
Figure 128. France Remdesivir (COVID-19) Value 2021-2025 ($ Millions)
Figure 129. UK Remdesivir (COVID-19) Consumption 2021-2025 (K Units)
Figure 130. UK Remdesivir (COVID-19) Value 2021-2025 ($ Millions)
Figure 131. Italy Remdesivir (COVID-19) Consumption 2021-2025 (K Units)
Figure 132. Italy Remdesivir (COVID-19) Value 2021-2025 ($ Millions)
Figure 133. Russia Remdesivir (COVID-19) Consumption 2021-2025 (K Units)
Figure 134. Russia Remdesivir (COVID-19) Value 2021-2025 ($ Millions)
Figure 135. Spain Remdesivir (COVID-19) Consumption 2021-2025 (K Units)
Figure 136. Spain Remdesivir (COVID-19) Value 2021-2025 ($ Millions)
Figure 137. Egypt Remdesivir (COVID-19) Consumption 2021-2025 (K Units)
Figure 138. Egypt Remdesivir (COVID-19) Value 2021-2025 ($ Millions)
Figure 139. South Africa Remdesivir (COVID-19) Consumption 2021-2025 (K Units)
Figure 140. South Africa Remdesivir (COVID-19) Value 2021-2025 ($ Millions)
Figure 141. Israel Remdesivir (COVID-19) Consumption 2021-2025 (K Units)
Figure 142. Israel Remdesivir (COVID-19) Value 2021-2025 ($ Millions)
Figure 143. Turkey Remdesivir (COVID-19) Consumption 2021-2025 (K Units)
Figure 144. Turkey Remdesivir (COVID-19) Value 2021-2025 ($ Millions)
Figure 145. GCC Countries Remdesivir (COVID-19) Consumption 2021-2025 (K Units)
Figure 146. GCC Countries Remdesivir (COVID-19) Value 2021-2025 ($ Millions)
Figure 147. Gilead Sciences Remdesivir (COVID-19) Market Share (2018-2020)
Figure 148. Bright Gene Remdesivir (COVID-19) Market Share (2018-2020)
Figure 149. Kelun Pharma Remdesivir (COVID-19) Market Share (2018-2020)
Figure 150. Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Market Share (2018-2020)
Figure 151. Hainan Haiyao Remdesivir (COVID-19) Market Share (2018-2020)
Figure 152. Inovio Pharmaceuticals Remdesivir (COVID-19) Market Share (2018-2020)
Figure 153. Borui Bio-Pharmaceutical Remdesivir (COVID-19) Market Share (2018-2020)
Figure 154. Berry Global Group Remdesivir (COVID-19) Market Share (2018-2020)
Please feel free to write an email to us or to use our electronic ticketing system.
